Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease

AIMS: To describe the use of warfarin and direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD), to evaluate changes in renal function over time and predictors of rapid decline, and to describe time in therapeutic range (TTR) and predictors of...

Descripción completa

Detalles Bibliográficos
Autores principales: Batra, Gorav, Modica, Angelo, Renlund, Henrik, Larsson, Anders, Christersson, Christina, Held, Claes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Arrhythmias and Sudden Death
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476150/
https://www.ncbi.nlm.nih.gov/pubmed/36104096
http://dx.doi.org/10.1136/openhrt-2022-002043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476150/
https://www.ncbi.nlm.nih.gov/pubmed/36104096
http://dx.doi.org/10.1136/openhrt-2022-002043

Ejemplares similares